CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- 4 Shares withheld for taxes President and CEO gave up 8,373 shares (to pay taxes)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4/A Open-market buy President and CEO bought 100,000 shares at $2.93 ($293,000)
- 4 Open-market sale President and CEO sold 100,000 shares at $2.93 ($293,000)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Medical Officer and SVP acquired 13,892 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP, CFO and Treasurer gave up 1,583 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 2,282 shares (to pay taxes)
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Shares withheld for taxes SVP, CFO and Treasurer gave up 1,717 shares (to pay taxes)
- 4 Option exercise See Remarks acquired 9,140 shares (option exercise)
Page 31 of 38 · 742 filings